COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status

BACKGROUND: Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID-19) vaccine are extremely limited in patients with decompensated cirrhosis. The vaccination campaign in this specific population could be difficult due to uncertainty about the adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhujun, Zhang, Chenxi, Zhao, Shuang, Sheng, Zike, Xiang, Xiaogang, Li, Ruokun, Qian, Zhuping, Wang, Yinling, Chen, Bin, Li, Ziqiang, Liu, Yuhan, An, Baoyan, Zhou, Huijuan, Cai, Wei, Wang, Hui, Gui, Honglian, Xin, Haiguang, Xie, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108345/
https://www.ncbi.nlm.nih.gov/pubmed/35578350
http://dx.doi.org/10.1186/s40249-022-00982-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108345/
https://www.ncbi.nlm.nih.gov/pubmed/35578350
http://dx.doi.org/10.1186/s40249-022-00982-0

Ejemplares similares